Skip to main content
. 2019 Sep 17;9:13476. doi: 10.1038/s41598-019-50067-6

Figure 6.

Figure 6

Elastic modulus (A) and hardness (B) of newly formed bone in the defects injected with bone marrow-derived mesenchymal stromal cells (BM-MSCs) or adipose tissue-derived mesenchymal stromal cells (AT-MSCs) 4 weeks post-injection compared with native bone. Data are presented as mean ± standard deviation (n = 3). No statistically significant differences were observed among the groups (p > 0.05).